Juan Miguel Suárez Rivero-rekin lankidetzan egindako argitalpenak (35)

2024

  1. A Multi-Target Pharmacological Correction of a Lipoyltransferase LIPT1 Gene Mutation in Patient-Derived Cellular Models

    Antioxidants, Vol. 13, Núm. 8

  2. Does Donor Age Have Effects on Senescence Biomarkers in Kidney-Transplanted Patients?

    Antioxidants and Redox Signaling, Vol. 40, Núm. 13-15, pp. 751-758

  3. Does NLRP1 Inflammasome Activation in Immune Cells in Kidney Transplantation Relate with Donor Organ Age?

    Antioxidants and Redox Signaling, Vol. 41, Núm. 7-9, pp. 479-487

  4. NLRP1 inflammasome promotes senescence and senescence-associated secretory phenotype

    Inflammation Research, Vol. 73, Núm. 8, pp. 1253-1266

  5. Polydatin and Nicotinamide Rescue the Cellular Phenotype of Mitochondrial Diseases by Mitochondrial Unfolded Protein Response (mtUPR) Activation

    Biomolecules, Vol. 14, Núm. 5

  6. The NLRP3 inhibitor Dapansutrile improves the therapeutic action of lonafarnib on progeroid mice

    Aging Cell, Vol. 23, Núm. 9

2023

  1. Alpha-lipoic acid supplementation corrects pathological alterations in cellular models of pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels

    Orphanet journal of rare diseases, Vol. 18, Núm. 1, pp. 80

  2. Neurodegeneration, Mitochondria, and Antibiotics

    Metabolites, Vol. 13, Núm. 3

  3. Vicious cycle of lipid peroxidation and iron accumulation in neurodegeneration

    Neural Regeneration Research, Vol. 18, Núm. 6, pp. 1196-1202

  4. mtUPR Modulation as a Therapeutic Target for Primary and Secondary Mitochondrial Diseases

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

2022

  1. Activation of the Mitochondrial Unfolded Protein Response: A New Therapeutic Target?

    Biomedicines, Vol. 10, Núm. 7

  2. Modeling Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes Syndrome Using Patient-Derived Induced Neurons Generated by Direct Reprogramming

    Cellular reprogramming, Vol. 24, Núm. 5, pp. 294-303

  3. Pantothenate and L-Carnitine Supplementation Improves Pathological Alterations in Cellular Models of KAT6A Syndrome

    Genes, Vol. 13, Núm. 12

  4. Pterostilbene in Combination With Mitochondrial Cofactors Improve Mitochondrial Function in Cellular Models of Mitochondrial Diseases

    Frontiers in Pharmacology, Vol. 13

  5. Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels

    Orphanet journal of rare diseases, Vol. 17, Núm. 1, pp. 311

  6. UPRmt activation improves pathological alterations in cellular models of mitochondrial diseases

    Orphanet Journal of Rare Diseases, Vol. 17, Núm. 1

  7. Vitamin E prevents lipid peroxidation and iron accumulation in PLA2G6-Associated Neurodegeneration

    Neurobiology of Disease, Vol. 165

2021

  1. Coenzyme q10 analogues: Benefits and challenges for therapeutics

    Antioxidants, Vol. 10, Núm. 2, pp. 1-20

  2. Down regulation of the expression of mitochondrial phosphopantetheinyl-proteins in pantothenate kinase-associated neurodegeneration: pathophysiological consequences and therapeutic perspectives

    Orphanet Journal of Rare Diseases, Vol. 16, Núm. 1

  3. From mitochondria to atherosclerosis: The inflammation path

    Biomedicines, Vol. 9, Núm. 3, pp. 1-24